What Has Been The Evolution of the Hydrocortisone Market in Recent Years?
The hydrocortisone market has seen considerable growth due to a variety of factors.
• The hydrocortisone market has grown significantly in recent years. It will increase from $1.52 billion in 2024 to $1.62 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.7%.
The growth is driven by the rising prevalence of skin disorders, an aging population, greater awareness and accessibility, growth in the pharmaceutical industry, and expanding markets.
What Are the Future Growth Projections for the Hydrocortisone Market?
The hydrocortisone market is expected to maintain its strong growth trajectory in upcoming years.
• The hydrocortisone market is expected to grow to $2.09 billion by 2029, at a CAGR of 6.5%.
Growth is attributed to technological advancements, increased OTC demand, R&D investments, rising disposable income, and expanded distribution channels. Trends include natural ingredient focus, combination therapies, personalized treatments, hydrocortisone-infused products, and sustainability efforts.
What Are The Core Factors Supporting Growth In The Hydrocortisone Market?
The growing prevalence of inflammatory and autoimmune diseases is likely to drive the hydrocortisone market. These diseases, where the immune system attacks the body’s tissues, are leading to an increased need for treatment options. Hydrocortisone is used to treat conditions like severe asthma exacerbations, helping to reduce inflammation and improve breathing. For instance, in May 2024, the National Center for Health Statistics reported that asthma prevalence in the U.S. increased from 8.4% in 2021 to 8.7% in 2022, contributing to the growth in hydrocortisone demand.
What Are The Major Segments Within The Global Hydrocortisone Market?
The hydrocortisone market covered in this report is segmented –
1) By Type: Cream, Injection, Tablet
2) By Route Of Administration: Parenteral, Oral, Topical
3) By Application: Adrenocortical Dysfunction, Adrenergic Syndrome, High Blood Calcium, Thyroiditis, Rheumatoid Arthritis, Dermatitis, Asthma And Chronic Obstructive Pulmonary Disease, Other Application
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Cream: Topical Hydrocortisone Cream (0.5%, 1%, 2.5%), Hydrocortisone Ointment
2) By Injection: Hydrocortisone Sodium Succinate Injection, Hydrocortisone Acetate Injection
3) By Tablet: Oral Hydrocortisone Tablets (5mg, 10mg, 20mg), Extended-Release Hydrocortisone Tablets
Pre-Book The Hydrocortisone Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Market Trends Are Altering The Hydrocortisone Industry?
Leading firms in the hydrocortisone market are prioritizing combination therapies, such as creams fused with butyrate active components to increase the effectiveness of treatments and widen their range of products. The alliance of hydrocortisone and butyrate lotion presents a potential coaction in treating skin disorders by utilizing anti-inflammatory characteristics of hydrocortisone in conjunction with butyrate's immunomodulatory effects and ability to enhance skin barrier performance. For instance, J. Molner AS., a pharmaceutical company based in Estonia, made a significant step in its global market strategy by launching Hydrocortisone Butyrate Lotion, 0.1%, in the United States in November 2023. The recently made available lotion is committed to treating inflammatory skin disorders, depicting Molner's dedication toward bolstering its international market footprint.
Who Are the Key Players In The Hydrocortisone Market?
Major companies operating in the hydrocortisone market are:
• Pfizer Inc.
• Johnson & Johnson
• Merck & Co Inc
• AbbVie Inc.
• Bayer AG
• Novartis AG
• The Dow Chemical Company
• GlaxoSmithKline plc (GSK)
• Viatris Inc.
• Solvay SA
• Teva Pharmaceutical Industries Ltd.
• Alcon Inc
• Sandoz International GmbH
• Valeant Pharmaceuticals International Inc
• Fresenius Kabi AG
• Macleods Pharmaceuticals Limited
• Sun Pharmaceutical Industries Ltd.
• Bausch & Lomb Incorporated
• Hikma Pharmaceuticals PLC
• Aspen Pharmacare Holdings Limited
• Ivax Pharmaceuticals Inc
• Glenmark Pharmaceuticals Ltd.
• Torrent Pharmaceuticals Limited
• Impax Laboratories LLC
• Akorn Incorporated
• Taro Pharmaceutical Industries Ltd
• Lannett Company Inc
• Salix Pharmaceuticals Inc
What Is The Most Dominant Region In The Hydrocortisone Market?
North America was the largest region in the hydrocortisone market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hydrocortisone market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
